<DOC>
	<DOCNO>NCT00919373</DOCNO>
	<brief_summary>The main objective study compare time randomization first recurrence ventricular tachycardia ( VT ) patient undergo VT ablation ( stable VTs ) substrate ablation ( unstable VTs ) initial episode stable VT patient undergo ablation , group protection ICD .</brief_summary>
	<brief_title>Substrate Modification Stable Ventricular Tachycardia Addition Implantable Cardioverter Defibrillator ( ICD ) Therapy</brief_title>
	<detailed_description>The main objective study compare time randomization first recurrence VT patient undergo VT ablation ( stable VTs ) substrate ablation ( unstable VTs ) initial episode stable VT patient undergo ablation , group protection ICD . Prior ablation , patient undergo electrophysiologic study ( EPS ) program ventricular stimulation , aim reproduce clinical VT . Most patient coronary artery disease , systolic LV dysfunction , one episode clinical sustain VT one inducible VT electrophysiologic study . Since inducible VT become potential clinical VT ( 24 ) , attempt make ablate clinical stable VT , well inducible morphology , stable unstable . One follow 2 ablation strategy possible VT : - Substrate modification sinus rhythm case unstable induced monomorphic VT allow map ablation tachycardia , noninducible stable clinical VT. - VT ablation tachycardia case stable VT For procedure number tachycardia , type tachycardia ( inducible noninducible , stable unstable ) , ablation strategy tachycardia ( possible lesion deploy one tachycardia render another tachycardia noninducible well ) procedural outcome tachycardia document .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Ventricular Dysfunction</mesh_term>
	<mesh_term>Tachycardia , Ventricular</mesh_term>
	<mesh_term>Ventricular Dysfunction , Left</mesh_term>
	<criteria>Coronary artery disease For purpose study , coronary artery disease define presence 50 % diameter stenosis leave main coronary artery , 75 % diameter stenosis leave anterior descending , circumflex right coronary artery , history surgical percutaneous revascularization procedure , history successful thrombolysis , history prior myocardial infarction ( e.g . : document Qwave , Rreduction , aneurysm ) Left ventricular ejection fraction â‰¤ 50 % estimate echocardiography contrast ventriculography within previous 30 day evidence old myocardial infarction ( ECG , echocardiographic venticulographic ) . One episode document stable clinical VT without reversible cause Written inform consent Age &lt; 18 year &gt; 80 year Protruding LV thrombus preablation echocardiogram Acute myocardial infarction within precede 1 month Class IV NYHA heart failure Valvular heart disease mechanical heart valve preclude access leave ventricle Unstable angina Cardiac surgery involve cardiotomy ( CABG ) within past 2 month Serum creatinine &gt; 220 mmol/L ( 2.5 mg/dL ) Thrombocytopenia coagulopathy Contraindication heparin Pregnancy Acute illness active systemic infection Other disease process likely limit survival le 12 month Significant medical problem opinion principal investigator would preclude enrollment study Participation another investigational study Unwillingness participate lack availability followup Incessant VT electrical storm Bundle branch reentry tachycardia present VT Preexisting ICD</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Catheter Ablation</keyword>
	<keyword>Defibrillators , Implantable</keyword>
</DOC>